Ignacio Aliagas,Stefan Gradl,Janet Gunzner,Wendy Lee,Simon Mathieu,Joachim Rudolph,Zhaoyang Wen,Guiling Zhao,Alexandre J. Buckmelter,Jonas Grina,Joshua D. Hansen,Ellen Laird,David Moreno,Li Ren,Steven
申请号：
US13393116
公开号：
US20130018033A1
申请日:
2010.08.27
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers, prodrugs and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
